Cargando…

Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report

Adalimumab is a fully human, recombinant, IgG1 monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha). It has been established that adalimumab can cross the placenta and can be detected in the fetal circulation for up to 6 months postpartum. However, clinical studies have failed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daham, Nujud, AlMuqrin, Abdullah, Madani, Abdulaziz, AlSaif, Fahad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666989/ https://www.ncbi.nlm.nih.gov/pubmed/33204064 http://dx.doi.org/10.2147/BTT.S273762

Ejemplares similares

The role of the “beret” sign and other markers in ultrasound diagnostic of the acrania–exencephaly–anencephaly sequence stages
por: Szkodziak, Piotr, et al.
Publicado: (2020)

Acrania-exencephaly-anencephaly sequence phenotypic characterization using two- and three-dimensional ultrasound between 11 and 13 weeks and 6 days of gestation
por: Martins Santana, Eduardo Félix, et al.
Publicado: (2018)

Fetal MRI Characteristics of Exencephaly: A Case Report and Literature Review
por: Sharif, Ali, et al.
Publicado: (2016)

Experimental exencephaly and myeloschisis in rats.
por: Hong, S. K., et al.
Publicado: (1989)

Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
por: Al Muqrin, Abdullah Muqrin, et al.
Publicado: (2022)

Exencephaly in a live, full term fetus
por: Renuka, I. V., et al.
Publicado: (2009)

Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
por: Madani, Abdulaziz, et al.
Publicado: (2021)

Monitoring the effect of TNF-alpha inhibitors on laboratory parameters and adverse effects in different diseases: a retrospective, single-center study
por: Madani, Abdulaziz N., et al.
Publicado: (2022)

SARS-CoV-2 infection with lytic and non-lytic immune responses: A fractional order optimal control theoretical study
por: Chatterjee, Amar Nath, et al.
Publicado: (2021)

Treating psoriasis with adalimumab
por: Alwawi, Eihab A, et al.
Publicado: (2008)

Amniotic Band Syndrome Associated with Exencephaly: A Case Report and Literature Review
por: da Silva, Aldo Jose F.
Publicado: (2019)

Customized Low-Cost 3D Printed Helmet as a Temporary Measure for a Patient with Acrania
por: Lucano, Luis Rene González, et al.
Publicado: (2019)

The Genetic Background of the Curly Tail Strain Confers Susceptibility to Folate-Deficiency-Induced Exencephaly
por: Burren, Katie A, et al.
Publicado: (2010)

Twenty-five year-old female with sudden onset itchy skin eruption over her upper back and chest three weeks after starting a ketogenic diet
por: Alkeraye, Salim, et al.
Publicado: (2019)

Mutations in Hedgehog Acyltransferase (Hhat) Perturb Hedgehog Signaling, Resulting in Severe Acrania-Holoprosencephaly-Agnathia Craniofacial Defects
por: Dennis, Jennifer F., et al.
Publicado: (2012)

Breast cancer recurrence after sentinel lymph node biopsy
por: AlSaif, Abdulaziz
Publicado: (2015)

Roles for Laminin in Embryogenesis: Exencephaly, Syndactyly, and Placentopathy in Mice Lacking the Laminin α5 Chain
por: Miner, Jeffrey H., et al.
Publicado: (1998)

Addition of Cyclosporine to Adalimumab Improved Psoriasis And Adalimumab-Induced Injection Site Reaction
por: Nakamizo, Satoshi, et al.
Publicado: (2014)

Adalimumab for severe psoriasis in Chilean paediatric patients()()
por: Armijo Fernandez, Daniela, et al.
Publicado: (2020)

Awareness and Acceptance of Digital Rectal Examination for the Clinical Evaluation of Anorectal Conditions Among the Saudi Population: A Cross-Sectional Study
por: Al Faifi, Jubran J, et al.
Publicado: (2023)

Cell necrosis, intrinsic apoptosis and senescence contribute to the progression of exencephaly to anencephaly in a mice model of congenital chranioschisis
por: Oria, Marc, et al.
Publicado: (2019)

Drug focus: adalimumab in the treatment of moderate to severe psoriasis
por: Vena, Gino A, et al.
Publicado: (2007)

Adalimumab in Recalcitrant Severe Psoriasis Associated with Atopic Dermatitis
por: Yayli, Savas, et al.
Publicado: (2013)

Visual Loss Induced by Adalimumab Used for Plaque Psoriasis
por: Saffra, Norman, et al.
Publicado: (2017)

An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
por: Zhou, Xin, et al.
Publicado: (2021)

Erythromelanosis follicularis faciei et colli with reticulated hyperpigmentation of the extremities
por: Al‐Saif, Fahad Mohammad, et al.
Publicado: (2017)

Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
por: de Natividade, Natallia Barreiros, et al.
Publicado: (2017)

A complication in a patient with hidradenitis suppurativa taking adalimumab
por: Perez, Olivia D., et al.
Publicado: (2022)

Robust model selection using the out-of-bag bootstrap in linear regression
por: Rabbi, Fazli, et al.
Publicado: (2022)

Thalamic stroke in a young adult with severe psoriasis refractory to adalimumab
por: Kadayakkara, Deepak Kana, et al.
Publicado: (2015)

Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence
por: Lombardi, G, et al.
Publicado: (2016)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Okita, Aline Lissa, et al.
Publicado: (2020)

Resolution of post-adalimumab vitiligo with secukinumab in a patient with psoriasis vulgaris
por: Palazzo, Giovanni
Publicado: (2020)

Rituximab-Induced Psoriasis in a Patient with Granulomatosis with Polyangitis Treated with Adalimumab
por: Alahmari, Hana S., et al.
Publicado: (2019)

The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis
por: Panahi, M., et al.
Publicado: (2021)

Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy
por: KOKOLAKIS, Georgios, et al.
Publicado: (2020)

Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
por: Bellinato, Francesco, et al.
Publicado: (2022)

Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis
por: Zhang, Si, et al.
Publicado: (2022)

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Fitzgerald, Timothy, et al.
Publicado: (2023)

Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting
por: Papp, K.A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9sub2bmg2j5qurdfve19n9h3dm